Roivant Sciences Ltd. (ROIV) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Biotechnology
Roivant Sciences Ltd. (ROIV) Profile & Business Summary
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Key Information
| Ticker | ROIV |
|---|---|
| Exchange | NASDAQ |
| Official Site | https://roivant.com |
Market Trend Overview for ROIV
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-08-28 (ET)
As of 2026-08-28, ROIV is showing signs of slowing down. Over the longer term, the trend remains bullish.
ROIV last closed at 34.71. The price is about 1.7 ATR below its recent average price (36.24), and the market is currently in a trend that may be losing strength. Price at 34.71 is near moderate support around 34.56. Momentum may slow, while light resistance sits near 35.70. View Support & Resistance from Options
The broader uptrend is still intact, but price has moved far from its recent average, increasing the risk of a pullback.
Trend score: 55 out of 100. Overall alignment is unclear. The market is currently in a late-stage trend that may be losing strength. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 32.87. If price falls below this area, the current structure would likely weaken further.
On 2026-08-28, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
There was no clear sign of meaningful positions being carried into the overnight session.
The model stays neutral because the setup is not clear enough to justify a directional deployment.
The model does not deploy this setup because the signal stack remains conflicted. Predictability is 54%, agreement is 59%, and reversal risk is 14%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 27 trading days, with turnover-based decay. The sample period is 2026-07-23 to 2026-08-28. The current price is 34.71, 2.51% below the estimated average cost of 35.60. An estimated 21.9% of recent positioning is below the current price, while 76.8% is above it. The peak-density price is 36.28. The largest concentrated cost region is 35.91 to 36.59 and contains 34.0% of the estimated distribution. The current price is within the 34.55 to 34.87 cost region. The nearest region below the current price is 33.73 to 33.93. The nearest region above the current price is 34.93 to 35.41.
Short Interest & Covering Risk for ROIV
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is relatively low, indicating limited pressure from short positions. (Historical percentile: 38%)
Structure Analysis
ROIV Short positioning looks normal. Current days to cover is 8.0 trading days, meaning short positions would unwind somewhat slower than average. Short covering is likely to have a normal impact on price moves. No meaningful structural fragility is currently detected (Fragility Score 0/100, DTC percentile 71%) and liquidity softening modestly (volume -8%).
Risk Summary
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
Why Price Reactions May Be Stronger?
Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-07-31 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.